William Kevin Kelly, Sandy Srinivas, Joseph Maly, Deepak Kilari, Arif Hussain, Biren Saraiya, Bilal Ahmed Siddiqui, Paul Monk, Gurkamal S. Chatta, Vivek Narayan, Divya Rana, Pradeep Thanigaimani, Fang Fang, Dimitris Skokos, Jessica Kirshner, Frank A. Seebach, Israel Lowy, Matthew Ingham, Sabina Sandigursky, Elizabeth Miller. "Phase 1/2 study of REGN4336 alone or in combination with cemiplimab or nezastomig in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps295